V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019272 | 220013857 | 0 | null | Palliative (P) | 2015-07-10 | 2015-07-10 | Hydroxycarbamide | N | null | 220026839 | HYDROXYCARBAMIDE |
| 220019273 | 220013857 | 1.03 | null | null | 2016-05-26 | 2016-05-26 | Hydroxycarbamide | N | null | 220026839 | HYDROXYCARBAMIDE |
| 220019275 | 220007009 | null | null | Palliative (P) | 2017-10-26 | 2017-11-12 | AML Interim Guidelines | 02 | N | 220026878 | NOT MATCHED |
| 220019277 | 220007017 | 1.83 | 68.1 | Disease modification (D) | 2016-12-04 | 2016-12-05 | Hydroxycarbamide | N | N | 220026891 | HYDROXYCARBAMIDE |
| 220019278 | 220007020 | 1.78 | 68 | null | null | 2016-09-29 | Cytarabine Low Dose | N | N | 220026895 | CYTARABINE |
| 220019279 | 220007024 | 1.04 | 12.4 | Curative (C) | null | 2016-04-10 | null | Y | null | 220026923 | NOT MATCHED |
| 220019280 | 220007026 | -1 | 107.5 | Curative (C) | 2017-01-17 | 2017-01-18 | Hydroxycarbamide | N | N | 220026928 | HYDROXYCARBAMIDE |
| 220019281 | 220007029 | null | null | Curative (C) | 2017-01-28 | 2017-04-05 | null | N | null | 220026950 | NOT MATCHED |
| 220019282 | 220007035 | null | 62.7 | Palliative (P) | null | 2017-02-12 | Hydroxycarbamide | 2 | N | 220026961 | HYDROXYCARBAMIDE |
| 220019283 | 220007040 | 1.57 | null | Palliative (P) | 2016-01-06 | 2016-01-13 | Cytarabine Low Dose | N | N | 220026962 | CYTARABINE |
| 220019285 | 220007044 | 1.8 | 79 | Disease modification (D) | 2018-08-20 | 2018-08-20 | CYTARABINE | null | null | 220026968 | CYTARABINE |
| 220019287 | 220007053 | 1.75 | 76.1 | Curative (C) | 2016-09-23 | 2016-11-10 | AML MyeChild 01 FLA | N | N | 220026988 | NOT MATCHED |
| 220019288 | 220007055 | 1.74 | 9.3 | Curative (C) | 2014-12-12 | 2015-01-23 | CYTARABINE + FLUDARABINE + MITOXANTRONE | N | N | 220027014 | NOT MATCHED |
| 220019289 | 220007059 | null | 72.45 | Curative (C) | 2019-02-18 | 2019-02-18 | CYTARABINE | null | null | 220027025 | CYTARABINE |
| 220019290 | 220007064 | 1.57 | 59 | Disease modification (D) | 2017-12-31 | 2018-01-25 | ATG + Cyclophosphamide TBI Allo | N | null | 220027042 | NOT MATCHED |
| 220019291 | 220007067 | null | 84.9 | null | 2017-05-04 | 2017-05-23 | Rituximab | N | N | 220027042 | RITUXIMAB |
| 220019292 | 220007068 | 0 | 65.7 | Disease modification (D) | 2014-05-29 | 2015-03-14 | Dasatinib | N | N | 220027059 | DASATINIB |
| 220019294 | 220019621 | 1.49 | 73.6 | null | 2016-10-26 | 2016-10-26 | Rituximab | N | N | 220027115 | RITUXIMAB |
| 220019295 | 220007076 | null | 76.6 | Curative (C) | 2017-04-13 | 2017-04-18 | Alemtuz+Fludara+Melphalan RIC MUD | null | null | 220027129 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019296 | 220007077 | 0 | 98.9 | Curative (C) | 2017-12-28 | 2018-03-16 | AML 18 TRIAL | 1 | N | 220027135 | AML18 TRIAL |
| 220019297 | 220013901 | null | 55 | Disease modification (D) | null | 2016-09-11 | AML 18 TRIAL | 1 | N | 220027145 | AML18 TRIAL |
| 220019298 | 220007086 | 1.58 | 72 | Curative (C) | 2016-04-10 | 2016-06-19 | AML18 PILOT TRIAL | null | N | 220027170 | PILOT TRIAL |
| 220019299 | 220007088 | 1.72 | 69.4 | Curative (C) | 2016-09-11 | 2016-11-03 | AML18 PILOT TRIAL | N | N | 220027179 | PILOT TRIAL |
| 220019300 | 220013909 | 0 | 76.5 | Curative (C) | 2014-01-12 | 2014-03-25 | AML 18 TRIAL | N | N | 220027205 | AML18 TRIAL |
| 220019301 | 220007098 | 1.82 | 0 | Disease modification (D) | 2016-04-27 | 2016-04-27 | Dasatinib | 02 | N | 220027219 | DASATINIB |
| 220019302 | 220007099 | 1.77 | 87.5 | Curative (C) | null | 2017-08-03 | AML18 PILOT TRIAL | Y | null | 220027227 | PILOT TRIAL |
| 220019303 | 220007100 | 1.77 | 119 | Curative (C) | 2017-06-17 | 2017-06-26 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220027231 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019304 | 220007102 | 1.95 | 72.6 | Not known (9) | 2016-10-07 | 2016-10-11 | Dasatinib | null | N | 220027237 | DASATINIB |
| 220019305 | 220007104 | 1.6 | 44.3 | Palliative (P) | null | 2013-06-26 | AML 18 TRIAL | 1 | N | 220027247 | AML18 TRIAL |
| 220019306 | 220007113 | 1.82 | null | Curative (C) | 2016-08-22 | 2016-08-23 | Rituximab | N | null | 220027295 | RITUXIMAB |
| 220019307 | 220007117 | 1.6 | 0 | Curative (C) | 2018-03-15 | 2018-09-29 | Dasatinib | N | N | 220027304 | DASATINIB |
| 220019308 | 220007119 | null | 40.3 | Curative (C) | 2015-01-13 | 2015-01-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220027307 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019309 | 220007120 | 1.82 | 99.7 | Curative (C) | 2014-06-07 | 2014-12-27 | Dasatinib | N | N | 220027314 | DASATINIB |
| 220019310 | 220013927 | 1.67 | 55.5 | Adjuvant (A) | 2013-11-04 | 2013-11-04 | Dasatinib | N | N | 220027337 | DASATINIB |
| 220019311 | 220007128 | null | 66.6 | Curative (C) | 2015-06-04 | 2015-06-21 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | null | 220027359 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019312 | 220007129 | 1.7 | 121 | Curative (C) | 2013-11-30 | 2013-11-30 | Dasatinib | 02 | N | 220027366 | DASATINIB |
| 220019313 | 220007132 | 1.95 | null | Palliative (P) | 2018-03-23 | 2018-03-23 | Dasatinib | 2 | N | 220027371 | DASATINIB |
| 220019314 | 220007137 | null | null | null | 2014-08-16 | 2015-02-01 | Dasatinib | null | N | 220027403 | DASATINIB |
| 220019315 | 220007140 | 1.71 | null | Neo-adjuvant (N) | 2017-07-02 | 2017-07-02 | Dasatinib | 2 | N | 220027407 | DASATINIB |
| 220019316 | 220013936 | null | 0 | Curative (C) | 2015-06-21 | 2017-08-10 | Dasatinib | 2 | N | 220027430 | DASATINIB |
| 220019317 | 220007145 | null | 0 | Curative (C) | 2015-08-27 | 2015-08-27 | Dasatinib | 02 | N | 220027439 | DASATINIB |
| 220019318 | 220019636 | 1.67 | 84.1 | Curative (C) | 2016-08-25 | 2016-09-07 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220027456 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019319 | 220007152 | 1.64 | 66.6 | Curative (C) | 2016-09-28 | 2016-10-09 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220027472 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019320 | 220007157 | null | 78.6 | Curative (C) | 2015-03-19 | 2015-03-19 | Dasatinib | 02 | N | 220027479 | DASATINIB |
| 220019321 | 220007159 | 0 | null | Disease modification (D) | 2016-05-16 | 2016-05-21 | Dasatinib | N | N | 220027491 | DASATINIB |
| 220019322 | 220017590 | 1.55 | 67.2 | Curative (C) | 2016-08-13 | 2016-08-18 | AML18 PILOT TRIAL | N | null | 220027491 | PILOT TRIAL |
| 220019323 | 220007160 | null | 0 | Curative (C) | 2015-07-25 | 2015-07-27 | AML 18 TRIAL | N | null | 220027501 | AML18 TRIAL |
| 220019324 | 220019640 | null | 56 | Curative (C) | 2015-01-09 | 2015-07-31 | Dasatinib | N | N | 220027506 | DASATINIB |
| 220019325 | 220007163 | 1.83 | 95.2 | Curative (C) | 2013-10-26 | 2013-10-27 | AML18 PILOT TRIAL | N | N | 220027516 | PILOT TRIAL |
| 220019326 | 220007164 | 1.7 | 111.5 | Adjuvant (A) | 2017-04-28 | 2017-05-02 | Dasatinib | 02 | N | 220027518 | DASATINIB |